With a significant expansion of researcher-driven clinical trials and a sharp focus on the region’s distinct healthcare needs, Penn State Cancer Institute (PSCI) is bringing the latest in cancer treatments to central Pennsylvania.
By marshaling a collaborative team of specialists and subspecialists at two locations in central Pennsylvania, Penn State Heart and Vascular Institute enables patients with even the most complex cardiovascular conditions to receive innovative, high-level care locally.
Merging the capabilities of MRI and ultrasound technology in real time, Penn State Health Milton S. Hershey Medical Center uses MRI-guided fusion biopsy to more accurately detect the presence and aggressiveness of prostate cancer. This innovative technique facilitates accurate prostate cancer diagnosis while reducing the possibility of nondiagnostic biopsies and the need for repeat procedures.
3D-printed models and implants have revolutionized craniofacial and other reconstructive surgeries at Penn State Health Milton S. Hershey Medical Center, and current research on bioprinting promises even more astonishing advances in treatment.
Two years after adopting the WATCHMAN and MitraClip technologies, WellSpan York Hospital has become a high-volume center for structural heart procedures, fostering excellent outcomes and remarkable levels of patient satisfaction.
Penn State Cancer Institute is the first and only healthcare facility in central Pennsylvania to offer the leading-edge treatment CAR-T cell (CAR-T) therapy to adult patients with lymphoma who have exhausted all other options. Kite Pharma, a division of Gilead, chose just a handful of U.S. facilities for its rollout of the potentially lifesaving treatment, Yescarta, which uses gene editing to boost patients’ own T cells against their cancer.
Cancer treatment summons to mind images of patients passively undergoing chemotherapy or radiation treatment, not actively participating in a program of exercise to alleviate symptoms and enhance outcomes.
Penn State Health St. Joseph Cancer Center integrates tissue-sparing yttrium-90 selective internal radiation therapy (Y-90 SIRT) into treatment of liver cancer, offering many local patients improved outcomes over conventional treatments alone.
Armed with the Flex Robotic System, experienced surgeons at Penn State Health Milton S. Hershey Medical Center can offer patients with human papillomavirus-induced head and neck cancers an advanced, local treatment option that is significantly less invasive than conventional open surgery.
Penn State Health Milton S. Hershey Medical Center’s advanced abdominal wall reconstruction techniques make it a referral destination for complex hernia surgery — even for patients from well beyond the academic medical center’s traditional catchment area.
Microsurgical flap procedures reconstruct breasts using patients’ own adipose tissue, creating a more natural appearance than saline or silicone implants. These procedures, which locally are performed only at Penn State Health Milton S. Hershey Medical Center, are also safer options for breast cancer patients who have undergone radiation therapy and mastectomy.
When two major movers in the region join together for improved health care and access, it’s a win-win for patients.
Empowered by leadership committed to technological advancement, clinical research, quality, safety and collaboration, Penn State Heart and Vascular Institute continues to build on its more than 60-year legacy as a regional destination for leading-edge, complex cardiovascular care.
Penn State Health Milton S. Hershey Medical Center providers leverage proven technology, high-level training and rigorous scientific inquiry to treat a broad spectrum of intractable neurological conditions, while laying the foundation for treatments that may help even larger patient populations.
From advanced pediatric medical and surgical care to in-house research and collaborative clinical investigation with national pediatric leaders, the scientists, providers and care teams at Penn State Children’s Hospital continue to break down barriers to inform treatment and foster excellent outcomes for children and families throughout Pennsylvania and the surrounding region.
A rigorous emphasis on primary and specialty care, research, and education sets Penn State Health Milton S. Hershey Medical Center apart in regional healthcare delivery.
As a healthcare administrator for more than 30 years, I have seen dramatic transformations in health care, but the greatest change has been in cardiovascular surgery. Thirty years ago, I would not have believed that most heart surgeries would someday be performed with tiny incisions in the side of the chest or groin. One of the greatest rewards of working at PinnacleHealth has been witnessing firsthand how these advances have helped patients right here in Central Pennsylvania.
At Penn State Health Milton S. Hershey Medical Center, physician-scientists provide advanced treatments for acute and chronic heart conditions, while furthering the Heart and Vascular Institute’s mission to develop and perfect lifesaving therapies and technologies.
As technologies and techniques have advanced in recent years, Gamma Knife radiosurgery has become a vital tool for enhancing outcomes among patients with brain tumors and other complex neurological disorders. Penn State Health Milton S. Hershey Medical Center recently reaffirmed its long-standing commitment to provide the most advanced care in the region by upgrading to the latest iteration of the Gamma Knife radiosurgery system: Leksell Gamma Knife®Icon™.
ESTABLISHED IN 2000, Penn State Cancer Institute, recognized as an American College of Surgeons Commission on Cancer-accredited facility, has evolved into a premier academic oncology center that encompasses clinical care, research, education and outreach. Since 2009, the 178,000-square-foot facility on the Milton S. Hershey Medical Center campus has served as the hub for nearly 160 clinicians, researchers and faculty members based in Hershey and University Park, State College in Centre County. The Cancer Institute care teams see nearly 2,000 individual cases annually.